CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.7B, above the global median of $1.18B
- FinancialsAltman Z-Score 2.17: grey zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.70BUSDvs all stocks (USD)
Trailing P/E
14.35xRevenue (TTM)
1.21BUSDvs all stocks (USD)
Profit Margin
10.48%Beta
0.9320xvs all stocks
52-Week Change
-7.87%vs all stocks
Market Capitalization
1.70BUSDvs all stocks (USD)
Enterprise Value
1.97BUSDvs all stocks (USD)
Trailing P/E
14.35xForward P/E
23.19xPEG Ratio
-0.0478xPrice to Sales (TTM)
1.40xPrice to Book (MRQ)
0.9113xEnterprise to Revenue
1.63xEnterprise to EBITDA
7.35xGross Margin
44.96%Profit Margin
10.48%Operating Margin
6.51%Return on Assets (TTM)
2.71%Return on Equity (TTM)
6.85%Revenue (TTM)
1.21BUSDvs all stocks (USD)
Revenue per Share (TTM)
5.29USDUpdated Sep 27, 2026Quarterly Revenue Growth
4.60%Gross Profit (TTM)
566.88MUSDvs all stocks (USD)
EBITDA (TTM)
336.68MUSDvs all stocks (USD)
Net Income (TTM)
126.77MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
4.58%Operating Cash Flow (TTM)
269.07MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
151.48MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 27, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
5.21MUSDFY2025 · Dec 31, 2025Revenue
1.18BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
600.40MUSDFY2025 · Dec 31, 2025Gross Profit
574.89MUSDFY2025 · Dec 31, 2025Operating Income
137.70MUSDvs all stocks (USD)
Pre-tax Income
263.36MUSDFY2025 · Dec 31, 2025Income Tax Expense
147.30MUSDFY2025 · Dec 31, 2025Net Income
116.05MUSDFY2025 · Dec 31, 2025EBIT
283.37MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
335.35MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
437.19MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
11.38MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
20.02MUSDFY2025 · Dec 31, 2025EPS (Basic)
0.4900USDFY2025 · Dec 31, 2025EPS (Diluted)
0.4800USDFY2025 · Dec 31, 2025Basic Shares Outstanding
233.87MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
233.87MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
116.05MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
-1.90MUSDFY2025 · Dec 31, 2025Operating Cash Flow
410.36MUSDFY2025 · Dec 31, 2025Free Cash Flow
329.89MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
285.28MUSDFY2025 · Dec 31, 2025Interest Paid
21.72MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
116.05MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
197.01MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
144.49MUSDFY2025 · Dec 31, 2025Stock-based Compensation
44.93MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-5.74MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
1.09MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
44.00KUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-87.54MUSDFY2025 · Dec 31, 2025Capital Expenditures
-80.47MUSDFY2025 · Dec 31, 2025Net Acquisitions
-29.50MUSDFY2025 · Dec 31, 2025Purchase of Investments
-75.66MUSDFY2025 · Dec 31, 2025Sale of Investments
167.00KUSDFY2025 · Dec 31, 2025Other Investing Activity
55.08MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-130.39MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-10.70MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-38.87MUSDFY2025 · Dec 31, 2025Other Financing Charges
-3.23MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-52.81MUSDFY2025 · Dec 31, 2025Shares Outstanding
218.56MSharesUpdated Sep 27, 2026Float Shares
191.02MSharesUpdated Sep 27, 2026% Held by Insiders
1.88%vs all stocks
% Held by Institutions
8.14%vs all stocks
Total Cash (MRQ)
283.59MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.30USDUpdated Sep 27, 2026Total Debt (MRQ)
560.20MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.3011xCurrent Ratio (MRQ)
2.85xBook Value per Share (MRQ)
8.50USDUpdated Sep 27, 2026Total Assets
2.79BUSDvs all stocks (USD)
Total Current Assets
577.17MUSDFY2025 · Dec 31, 2025Total Liabilities
879.41MUSDFY2025 · Dec 31, 2025Total Non-current Assets
2.21BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
702.10MUSDFY2025 · Dec 31, 2025Total Current Liabilities
177.31MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
274.30MUSDFY2025 · Dec 31, 2025Accounts Receivable
51.27MUSDFY2025 · Dec 31, 2025Inventory
158.29MUSDFY2025 · Dec 31, 2025Accounts Payable
24.57MUSDFY2025 · Dec 31, 2025Short-term Debt
36.85MUSDFY2025 · Dec 31, 2025Long-term Debt
481.50MUSDFY2025 · Dec 31, 2025Common Stock (Book)
1.78BUSDFY2025 · Dec 31, 2025Retained Earnings
165.42MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
1.91BUSDvs all stocks (USD)
52-Week Low
5.29USDUpdated Sep 27, 202652-Week High
10.43USDUpdated Sep 27, 202652-Week Change
-7.87%vs all stocks
Beta
0.9320xvs all stocks
50-Day MA
7.34USDUpdated Sep 27, 2026200-Day MA
7.35USDUpdated Sep 27, 2026Avg 10-Day Volume
539.40KSharesUpdated Sep 27, 2026Avg 30-Day Volume
489.62KSharesUpdated Sep 27, 2026Diluted EPS (TTM)
0.5400USDUpdated Sep 27, 2026Other Income / Expense
134.30MUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.17: grey zoneSignificant
Altman Z-Score: 2.17
High earnings qualityNotable
Earnings Quality Score: 2.28
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.7B, above the global median of $1.18BNotable
Market cap (USD): 1,700,620,723Global Median: 1,180,223,658.953
Revenue is $1.21B, above the global median of $548.88MNotable
Revenue (USD): 1,209,371,008Global Median: 548,883,780.48
Levered free cash flow is $151.48M, above the global median of $18.73MNotable
Levered free cash flow (USD): 151,481,376Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Yifan Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Ani Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Olix Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Shenzhen Edge Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangxi Fushine Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shanghai Shyndec Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Beijing Aosaikang Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Alembic Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Absci Corporation
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Hugel Inc.
Tier 1ProductionApproval-Gated PipelineRule